Overview
- The research, published in The Lancet Digital Health in June 2026, reports a clinical prediction model developed and validated on anonymised GP records from more than 5.6 million people across England.
- The calculator estimates 1-, 5- and 10-year risk of serious muscle disorders and found that over 98% of GP-identified statin-eligible patients are predicted to have low ten-year risk.
- The model uses 22 routinely recorded factors such as age, sex, ethnicity, BMI, smoking, prior muscle problems, vitamin D deficiency and concurrent medications to produce individualized risk scores.
- Oxford University Innovation has made the tool available for potential clinical use and researchers intend it to be used alongside QRISK cardiovascular estimates, but real-world uptake and workflow integration remain to be seen.
- The study also flagged a public-health gap with more than 60% of eligible people not taking statins, a finding that could reshape doctor–patient discussions, monitoring strategies and efforts to improve prescribing and adherence.